Historical record - last NADAC effective date: 1/17/2018
Product Information
CEFIXIME 200 MG/5 ML SUSP is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $5.6934 per ML under NDC 68180040704. Its NADAC has been published 123 times since Apr 20, 2016.
FDA first approved this application on Apr 10, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
200 mg/5mL
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180040704
Classification
Generic
Dosage Form
POWDER, FOR SUSPENSION
Route
ORAL
Effective Date
1/17/2018
Active Ingredients
CEFIXIMEApproval Type
Generic (ANDA)
FDA Application
ANDA065355FDA Approved
4/10/2007
TE Code
AB
On Market Since
4/24/2015
Pharmacological Classes
Price Statistics
The NADAC for CEFIXIME 200 MG/5 ML SUSP has been published 123 times since Apr 20, 2016, and over the history we have for it it has declined 9.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $5.6934 per ML |
|---|---|
| All-time high | $6.3066 (Aug 10, 2016) |
| All-time low | $5.6934 (Jan 17, 2018) |
| Median price | $6.1240 |
| Average price | $5.9637 |
| Largest weekly change | -7.0% (Jan 17, 2018) |
| Weeks tracked | 123 |
| Tracking since | Apr 20, 2016 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-9.7%
Last surveyed Jan 16, 2019 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 35% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CEFIXIME 200 MG/5 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for CEFIXIME 200 MG/5 ML SUSP, manufactured by Lupin Pharmaceuticals Inc., is $5.6934 per ML (NDC 68180040704), effective Jan 16, 2019.
How has the price of CEFIXIME 200 MG/5 ML SUSP changed over time?
Over the history we have for it, the NADAC for CEFIXIME 200 MG/5 ML SUSP has declined 9.7%. It has been tracked across 123 weekly CMS publications since Apr 20, 2016.
What are the highest and lowest recorded NADAC prices for CEFIXIME 200 MG/5 ML SUSP?
Since Apr 20, 2016, the NADAC for CEFIXIME 200 MG/5 ML SUSP has ranged from a low of $5.6934 (Jan 17, 2018) to a high of $6.3066 (Aug 10, 2016), with a median of $6.1240 per ML.
Are there cheaper alternatives to CEFIXIME 200 MG/5 ML SUSP?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CEFIXIME 200 MG/5 ML SUSP, is $3.6836 per ML — about 35% below CEFIXIME 200 MG/5 ML SUSP.
Who manufactures CEFIXIME 200 MG/5 ML SUSP?
CEFIXIME 200 MG/5 ML SUSP (NDC 68180040704) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.